TARGETING GPNMB TO IMPROVE EFFICACY OF CDK4/6 INHIBITORS IN ER+ BREAST CANCER

$585,759FY2025Defense Health AgencyDOD

Emory University, Atlanta GA

Investigators

View source on USAspending →